Respiratory Syncytial Virus Vaccine Approaches: a Current Overview.

about

Respiratory Syncytial Virus Vaccine Approaches: a Current Overview.

Item

http://www.wikidata.org/entity/Q55534670

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Respiratory Syncytial Virus Vaccine Approaches: a Current Overview.

@en

Respiratory Syncytial Virus Vaccine Approaches: a Current Overview.

@nl

type

Item

label

Respiratory Syncytial Virus Vaccine Approaches: a Current Overview.

@en

Respiratory Syncytial Virus Vaccine Approaches: a Current Overview.

@nl

prefLabel

Respiratory Syncytial Virus Vaccine Approaches: a Current Overview.

@en

Respiratory Syncytial Virus Vaccine Approaches: a Current Overview.

@nl

P1476

Respiratory Syncytial Virus Vaccine Approaches: a Current Overview

@en

P2093

Antonieta Guerrero-Plata

http://www.w3.org/2001/XMLSchema#string

Carolyn M Clark

http://www.w3.org/2001/XMLSchema#string

P2860

Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody

Synthetic Biodegradable Microparticle and Nanoparticle Vaccines against the Respiratory Syncytial Virus

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus.

Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults.

Respiratory syncytial virus and parainfluenza virus.

Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine.

A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation

The burden of respiratory syncytial virus infection in young children

Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention.

P304

202-207

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40588-017-0074-6

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30009126

http://www.w3.org/2001/XMLSchema#string

P932

6040676

http://www.w3.org/2001/XMLSchema#string